Anti-epilepsy drug, topiramate, effective at preventing migraine headaches

Among patients with migraine headache, the antiepileptic drug topiramate appears effective in preventing migraine attacks and for reducing the use of rescue medication for headaches, according to a study in the February 25 issue of The Journal of the American Medical Association (JAMA).

"Migraine headache is a neurologic disorder associated with significant disability and impaired quality of life, adversely affecting daily activity and work-related productivity for many persons" according to background information in the article. The authors state that approximately 11 percent of the U.S. population experiences migraines and the prevalence is thought to be about the same in other industrialized countries.

Jan Lewis Brandes, M.D., from the Nashville Neuroscience Group, Nashville, Tenn., and colleagues, evaluated the efficacy and safety of topiramate for migraine prevention during a 26-week study conducted at 52 North American outpatient clinical centers. Four hundred eight-three patients were randomized to four treatment groups: placebo or topiramate at 50 milligrams/day (mg/d), 100 mg/d, or 200 mg/d. From that group, 468 (87-percent women) were included in the analysis after some participants dropped out of the study, most often because of adverse side-effects from the medication, including paresthesia (tingling sensations), fatigue, and nausea.

"Mean (average) monthly migraine frequency decreased significantly for patients receiving topiramate at 100 mg/d [milligrams per day] (-2.1) and topiramate at 200 mg/d (-2.4) vs. placebo (-1.1)," the authors report. "Statistically significant reductions occurred within the first month with topiramate at 100 and 200 mg/d." The researchers found that the participants in the 100 mg/d and 200 mg/d had reductions in the number of days with migraines per month, and were also able to reduce their rescue medication use for headaches, such as aspirin, acetaminophen, triptans, and opioids.


Contact: Jan Lewis Brandes, M.D.
JAMA and Archives Journals

Page: 1

Related medicine news :

1. Data shows new drug, rimonabant, helps smokers quit while limiting post cessation weight gain
2. Antiviral drug, valacyclovir, reduces genital herpes transmission
3. Hassle-free stroke prevention offered by new drug, Stanford researcher says
4. Common drug, given promptly, reduces incidence of post-traumatic stress disorder, small study finds
5. One drug, two targets
6. Non-drug, treatment for hypertension gets further physiological backing in AHAs Hypertension Primer
7. Substance found in sharks could lead to weight loss drug, research shows
8. Strategy effective against drug resistant tuberculosis
9. Study shows patch therapy may be as effective as oral medications
10. Chronic pain treatments more effective when taken together, new study shows
11. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints

Post Your Comments:

(Date:1/12/2020)... ... 2020 , ... Cecelia Health ( http://www.ceceliahealth.com ), a leading ... for over a decade to transform lives and health outcomes for patients and ... By optimizing the mix of expert clinician and digital touchpoints in clinically tested ...
(Date:1/10/2020)... ... January 10, 2020 , ... Sigma Theta Tau International ... Book of the Year Awards. These awards are regarded as one of the most ... year, the AJN Book of the Year competition has recognized Sigma for the last ...
(Date:1/10/2020)... ... 10, 2020 , ... WellHaven Pet Health, a family of companion animal veterinary ... coming in February 2020, LEAD WELL with WOMEN. The community will be showcased at ... of LEAD WELL with WOMEN is to empower women, engage all, connect, and help ...
(Date:1/10/2020)... ... January 10, 2020 , ... The value of healthy ... is via a preventative approach. Leading eye care doctor, Brent Bellotte MD., champions such ... many common eye diseases. , Eyesight is something that many take for granted until ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... Oregon, provides a friendly, non-intimidating environment for all women. In search for a ... its current and prospective members. , For nearly 30 years, Balanced Habits, ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... ... 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, a partnership ... Inc, operating under a tender from the Israeli Innovation Authority (IIA) has recently ... Tel-Aviv University and Glasgow University. , Epeius pharma develops next generation biological ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... an affiliation agreement that officially brings GCMC into the family of hospitals affiliated ... City provides the network and its patients with a vital new access point ...
(Date:1/10/2020)... ... January 10, 2020 , ... Representatives with MyBioGate announced that they are ... partners conference will be held on 12 January 2020 at the Grand Hyatt ... be your gateway to China’s healthcare and life science industry. For the overseas biopharmas ...
Breaking Medicine Technology:
Cached News: